发明名称 |
Method of administration of paclitaxel-plasma protein formulation |
摘要 |
The present invention provides for a method for treating human or animal patients with paclitaxel formulation, the method comprising an intratumoral dose of a paclitaxel formulation and an intravenous dose of paclitaxel. The intravenous dose occurs about 1 to about 7 days after the intratumoral dose. The paclitaxel formulation may typically be either a paclitaxel/HSA formulation or paclitaxel/gamma-globulin formulation.
|
申请公布号 |
US6569459(B2) |
申请公布日期 |
2003.05.27 |
申请号 |
US20010829744 |
申请日期 |
2001.04.10 |
申请人 |
TEVA PHARMACEUTICAL INDUSTRIES, LTD. |
发明人 |
FLASHNER-BARAK MOSHE |
分类号 |
A61K47/42;(IPC1-7):A61K9/14;A61K9/50;A61F2/00 |
主分类号 |
A61K47/42 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|